Lv5
826 积分 2023-07-27 加入
非酒精性脂肪性肝病中西医结合诊疗专家共识(2025年)
2天前
已完结
2型糖尿病合并代谢相关脂肪性肝病多学科管理专家共识（2026版）
2天前
已完结
GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization
4天前
已完结
Association of Semaglutide Treatment With Liver Cirrhosis and Hepatocellular Carcinoma in Type 2 Diabetes: A Population‐Based Cohort Study
4天前
已完结
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists
4天前
已完结
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown
4天前
已完结
AASLD ISDA Practice Guideline on treatment of chronic hepatitis B
5天前
已完结
Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B
5天前
已完结
Antiviral Therapy Reduces Hepatocellular Carcinoma and Cirrhosis Risk in Chinese Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase
5天前
已完结
Large-scale profile study on hepatitis B surface antigen levels in chronic hepatitis B: implications for drug development targeting functional cure
5天前
已完结
皖公网安备34019202002308